About our work

IMPACT TRIALS works with collaborators both nationally and internationally. There have been a number of completed trials with agents including; N-acetyl cysteine, minocycline, mitochondrial enhancers, asprin, and rosuvastatin. Data from these trials provides rich sources to explore not only primary efficacy but also underlying factors related to treatment response.

TRIALS ultimately aims both to provide interventions that can be rolled out into clinical practice and to identify factors that will enhance personalised medicine in psychiatry

Register your interest to participate in our research studies.

If you are interested in taking part in our research studies you can sign up to the database and we will keep you informed about current or future opportunities.